Meloxicam: Clinical Trials

15 trials of Meloxicam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown, 1 terminated, 1 withdrawn. 15 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 215Completed 9, Unknown 4, Terminated 1, Withdrawn 1
Phase 32Completed 1, Unknown 1

Follow Meloxicam: new trials by email Literature Review of Meloxicam trials Research Report on Meloxicam

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Ovulation in Obese Women
Levonorgestrel 1.5 milligram, Meloxicam 15 milligram, calcium carbonate 750 milligram - Pregnancy Prevention
Phase 2CompletedInnovaGyn, Inc.42023-12-102026-06-30
Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery
Meloxicam Injection 30mg, Meloxicam Injection 60mg, Nacl 0.9% - Pain, Post-operative
Phase 2UnknownBeijing Tide Pharmaceutical Co., Ltd1082023-07-012023-07-18
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo - Pregnancy Prevention
Phase 2CompletedInnovaGyn, Inc.192022-06-282026-09-09
Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials
Celecoxib, Naproxen, Meloxicam - Axial Spondyloarthritis
Phase 2TerminatedThe University of Texas Health Science Center, Houston422020-06-252025-08-13
Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis
Bawei Shenqi Pill, Bawei Shenqi Pill placebo, Meloxicam - Ankylosing Spondylitis
Phase 2 / Phase 3UnknownShanghai University of Traditional Chinese Medicine802017-10-012020-08-14
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
Meloxicam Test Capsules, Meloxicam Tablets - Osteoarthritis
Phase 2WithdrawnIroko Pharmaceuticals, LLC2015-05-012015-07-10
Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea
Meloxicam, Diclofenac Potassium, Placebo Oral - Dysmenorrhea
Phase 2 / Phase 3CompletedLaboratorios Andromaco S.A.682014-06-272019-05-03
A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Meloxicam, Filgrastim - Multiple Myeloma, Non-Hodgkin's Lymphoma
Phase 2CompletedSherif S. Farag382014-03-112021-02-21
Meloxicam vs Placebo for Mobilization
GCSF, meloxicam, Placebo - Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma
Phase 2CompletedMassachusetts General Hospital312013-10-012020-05-18
Discontinuing NSAIDs in Veterans With Knee Osteoarthritis
Meloxicam 15 mg po QD, Cognitive Behavioral Therapy - Knee Osteoarthritis
Phase 2CompletedVA Office of Research and Development4902013-09-022023-07-27
Study of a COX-2 Inhibitor for Prevention of Ovulation
Meloxicam - Rupture; Graafian Follicle
Phase 2UnknownInstituto Chileno de Medicina Reproductiva562011-01-012011-05-03
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
TNF alpha, NSAIDs and sulfasalazine - Ankylosing Spondylitis
Phase 2UnknownChung Shan Medical University3002009-11-012015-05-28
Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery
N1539, placebo, Motrin - Dental Pain
Phase 2CompletedAlkermes, Inc.2302009-07-012011-12-02
Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar
Meloxicam 7.5 mg, Meloxicam 3.75 mg, Meloxicam 1.875 mg - Pain
Phase 2CompletedBoehringer Ingelheim3811998-04-012014-07-08
Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea
Meloxicam 7.5 mg, Meloxicam 15 mg, Mefenamic acid 500 mg - Dysmenorrhea
Phase 2CompletedBoehringer Ingelheim3371998-01-012018-08-31

Conditions studied

Dysmenorrhea (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Multiple Myeloma (2)  ·  Spondylitis, Ankylosing (2)  ·  Axial Spondyloarthritis (1)  ·  Hodgkin Disease (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)  ·  Pain (1)  ·  Pain, Postoperative (1)  ·  Rupture (1)  ·  Spondylitis (1)  ·  Toothache (1)

Sponsors

Boehringer Ingelheim (2)  ·  InnovaGyn, Inc. (2)  ·  Alkermes, Inc. (1)  ·  Beijing Tide Pharmaceutical Co., Ltd (1)  ·  Chung Shan Medical University (1)  ·  Instituto Chileno de Medicina Reproductiva (1)  ·  Iroko Pharmaceuticals, LLC (1)  ·  Laboratorios Andromaco S.A. (1)  ·  Massachusetts General Hospital (1)  ·  Shanghai University of Traditional Chinese Medicine (1)  ·  Sherif S. Farag (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  VA Office of Research and Development (1)

Countries

United States (7)  ·  Chile (2)  ·  China (2)  ·  Taiwan (1)

Top investigators

Andrea Lukes, MD (1)  ·  Bimalangshu Dey, MD (1)  ·  David F. Archer, MD (1)  ·  Mark C Hwang, MD (1)  ·  Sherif Farag, M.D., Ph.D. (1)  ·  Steven Christensen, DDS (1)  ·  Wei C- C, M.D. (1)  ·  William L. McPheat, PhD (1)

Results publications

PMID 23114735, PMID 12441312, PMID 15541405, PMID 16009156, PMID 16798842, PMID 16855077, PMID 16980507, PMID 18929686, PMID 19933235, PMID 23040128, PMID 24835831, PMID 24909636, PMID 25259677, PMID 26025453, PMID 26830816, PMID 29329493, PMID 30737315, PMID 32702101, PMID 34510361, PMID 40676732

NIH funding

KL2TR003168 (1), R43HD104508 (1), R43HD107861 (1)